Transplant International · 1998 · 23 citations · 8 references
Life SciencesCell BiologyImmunologyCellular ImmunologyImmunoregulationInflammationCytokine BiologyCytokine RegulationCytokine SignalingFlow CytometryImmunosuppressionImmunosuppressive TherapyCytokine Release AssaysCytokine SynthesisFlow Cytometric AnalysisFlow Cytometric Cell AnalysisFlow Cytometry Immunophenotyping
The availability of a method to measure the effects of drugs on immune reactivity should be helpful in optimizing treatment after organ transplantation. Since cyclosporine A (CSA) interferes with activation of T cells and cytokine synthesis, production of IL-2 and IFN-gamma might constitute a marker of this drug's effects. We measured the capacity for mitogen-stimulated production of these cytokines in whole blood by using immunostaining of intracellular and membrane antigens, followed by flow cytometry. The percentage of CD4+ T cells producing IL-2 or IFN-gamma was strongly reduced in 20 transplant patients compared with 24 healthy controls. The capacity for IL-2 production of CD4+ and CD8+ cells correlated inversely with CSA blood levels (P values 0.0087 and 0.0396, respectively). IFN-gamma production by CD4+ T cells showed a negative correlation with the prednisolone dose (P = 0.0175) and, for the CD8+ subset, with CSA trough levels (P = 0.0023). These data show that inhibition of T cell cytokine synthesis by CSA and prednisolone can be quantified.
8
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Jun S. Liu, Jesse D. Farmer, Willam S. Lane et al. · Cell · 1991 · 4.1K citations
A. P. van den Berg, W. van der Bij, W.J. van Son et al. · Transplantation · 1989 · 185 citations